About
NP Screen has developed a diagnostic screening test for Nasopharyngeal Cancer. This genetic test allows people to determine whether or not they have the disease at a very early stage. Thereby improving their chances for a successful recovery. Our mission is to establish NP Screen as the precision standard for the early detection of nasopharyngeal cancer, and improve the quality of life and survival rates for individuals at risk for NPC worldwide. Continue to develop innovative screening technologies and conduct clinical studies in order to develop even more sensitive and quantifiable standards for the diagnosis of disease.
Technologies
Cloudflare DNS
Outlook
CloudFlare Hosting
Mobile Friendly
WordPress.org
Google Font API
YouTube
Keywords
early detection of nasopharyngeal carcinoma
medical equipment manufacturing
sample collection
medical devices
fda class ii device
diagnostic assay
healthcare equipment & supplies
fda-approved
b2c
global screening access
trans-oral brushing
d2c
ebv dna
diagnostic laboratories
viral dna detection
sample storage at room temperature
sample shipping logistics
real-time pcr
world health organization recognition
office-based procedure
life-saving technology
low resource settings
lab analysis
submucosal cancer detection
medical diagnostics
life-saving early detection
cancer screening
global availability
pcr analysis
health screening
Company Information
-
Employees 4
-
Founded 2011
-
Annual Revenue $15629000
Location
7155 Woodbine Ave, Markham, Ontario, Canada, L3R 1A3
